Guideline on diagnosis and management of osteoarthritis published
NICE’s new guideline aims to improve the management of osteoarthritis and the quality of life for people with this condition. It covers the diagnosis, assessment and non-surgical management of osteoarthritis.
It’s aimed at a wide audience including commissioners of social care services and people with osteoarthritis, their families and carers.
They’ve also produced a visual summary on recommendations for the management of osteoarthritis (PDF) and updated our quality standard.
Improving young adult diabetes services
NICE’s case study from the Royal Liverpool and Broadgreen University Hospitals NHS Trust focuses on patient engagement to improve clinical outcomes in young adult diabetes care.
The trust achieved this by adopting a culture of engagement, patient-centred care, flexibility and peer support to complement clinical care.
The article can be read here.
New web resource to help reduce health inequalities
NICE’s health inequalities web resource directs you to NICE-recommended, evidence-based approaches to address health inequalities. They’ve set these within the context of national priorities and aligned them with recognised health inequalities frameworks.
The reduction in health inequalities being linked to national priorities is of significance to help members understand why some new tests and technologies may be seen as priorities for adoption support if they match these criteria.
BIVDA is currently working to ensure any unmet needs or clinical pathways improvements identified by industry are also communicated back.
View the health inequalities resource here.
New era of collaboration
NICE have signed a collaborative arrangement with 5 leading health technology assessment agencies in the UK, Australia and Canada. The agreement aims to facilitate greater collaboration in 5 priority areas:
- future-proofing of health technology assessment systems
- collaborating with regulators
- work-sharing and efficiency gains
- digital and artificial intelligence technologies
Early value assessment for medical technologies
NICE are trialling an innovative new approach to the way we assess digital products, devices and diagnostics. By offering a rapid assessment based on clinical effectiveness and value for money, services and patients will be able to benefit sooner.
They’ve designed our early value assessment pilots to draw in the most promising and impactful medical technologies, where the evidence base is still developing.
Read more about it here.
- Type 2 diabetes in adults: management
Submit your comments by Monday 31 October 2022.
- Cirrhosis in over 16s: assessment and management
Submit your comments by Tuesday 1 November 2022.
- Acute kidney injury
Submit your comments by Friday 18 November 2022.